Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × Cyclosporins × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Biphenotypic, Acute 3 Myeloproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Prolymphocytic 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hodgkin Disease 2 Anemia, Refractory, with Excess of Blasts 2 Waldenstrom Macroglobulinemia 1 Rhabdomyosarcoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Hemoglobinopathies 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Desmoplastic Small Round Cell Tumor 1

Interventions

Cyclophosphamide 7 Biopsy 6 romidepsin 5 mogamulizumab 5 fludarabine 5 Brentuximab Vedotin 5 pembrolizumab 4 fludarabine phosphate 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 ruxolitinib 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Depsipeptides 3 hypericin 2 belinostat 2 Whole-Body Irradiation 2 Tacrolimus 2 Melphalan 2 Lactones 2 Etoposide 2 Busulfan 2 Bexarotene 2 trastuzumab biosimilar HLX02 1 tofacitinib 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡